Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
In clinical trials, a typical approach for evaluation of safety and efficacy of a test treatment under investigation is to first test for the null hypothesis of no treatment difference in efficacy based on clinical data collected under a valid trial design. If significant, the investigator would reject the null hypothesis of no treatment difference and then conclude the alternative hypothesis that there is a difference in favor of the test treatment.See at www.omicsonline.org/open-access/some-thoughts-on-precision-medicine-2155-6180-1000269.php
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi